Health Care & Life Sciences » Pharmaceuticals | Yungjin Pharm. Co. Ltd.

Yungjin Pharm. Co. Ltd. | Mutual Funds

Mutual Funds that own Yungjin Pharm. Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
1,280,597
0.7%
98,411
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
982,461
0.54%
0
0.01%
09/05/2018
Government Pension Fund - Global (The)
677,608
0.37%
181,180
0%
12/31/2017
590,712
0.32%
0
1.08%
09/06/2018
Vanguard Developed Markets Index Fund
478,591
0.26%
0
0%
07/31/2018
Mirae Asset TIGER 200
320,536
0.18%
-19,054
0.08%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
265,384
0.14%
0
0.01%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
208,232
0.11%
0
0.02%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
196,383
0.11%
0
0.02%
09/05/2018
Mirae Asset TIGER Health Care ETF
178,852
0.1%
44,223
0.86%
04/30/2018

About Yungjin Pharm. Co.

View Profile
Address
13 Olympic-ro 35da-gil
Seoul SL 05510
Korea, Republic Of
Employees -
Website http://www.yungjin.co.kr
Updated 07/08/2019
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.